ADA and Lilly Clinical Research Award on Diabetes Care in Older Adults
The American Diabetes Association (ADA) and Lilly Clinical Research Award: Diabetes Care in Older Adults provides grant support for clinical and translation studies focused on improving the evidence base and understanding of the goals, barriers, and effects of treatments and interventions (beneficial and adverse) in the older adult population with diabetes. Up to three awards will be funded, which will each receive a maximum of $200,000 per year for a total of $550,00 over a term of three years.
The American Diabetes Association (ADA), through support provided by Eli Lilly and Company, is requesting applications for original and innovative Translational and Clinical Research proposals focusing on improving the evidence base and understanding of the goals, barriers, and effects of treatments and interventions (beneficial and adverse) in the older adult population with both type 1 and type 2 diabetes. The eventual aim of this research initiative is to further identify the safest and most effective means of diabetes treatment for this population. Up to three awards will be funded, which will each receive a maximum of $200,000 per year for a total of $550,00 over a term of three years. Indirect costs are limited to 15% of the total direct costs.
For more information on application guidelines, eligibility, and terms and conditions, you can read the RFA announcement here.
- Application instructions and budget forms are online at http://professional.diabetes.org/grants under Targeted Awards.
- All applications must be submitted online no later than September 16, 2013, with anticipated funding January 1, 2014.
- Questions about this request for applications should be addressed to grantquestions@diabetes.org.
